IMU 1.85% 5.3¢ imugene limited

Ann: Imugene & Kincell Bio Strategic Partnership Investor Webinar, page-10

  1. 3,232 Posts.
    lightbulb Created with Sketch. 7060
    It’s a derisking moment. If the Azer-Cel trials were to fail we’ve already got our money back and we are off the hook.

    If they are a big success, we’ve got our supply lines sorted. And the cost of goods will be insignificant once the drugs hit the market. Probably around $3-$400k patient for The first indication. Seriously big money.

    Once the first 10 cohort in the confirmation trial is successful, this is ready to licence or sell off.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.3¢
Change
-0.001(1.85%)
Mkt cap ! $389.5M
Open High Low Value Volume
5.5¢ 5.6¢ 5.3¢ $615.0K 11.39M

Buyers (Bids)

No. Vol. Price($)
25 2977440 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.4¢ 283236 4
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.